Literature DB >> 15046277

Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants.

G Distefano1, R Curreri, P Betta, M G Romeo, M Amato.   

Abstract

AIM: To determine reference values for procalcitonin (PCT) and C-reactive protein (CRP) for gestational age and to use these parameters as diagnostic markers of perinatal bacterial and fungal infection.
METHODS: PCT and CRP serum levels were measured in a case-control study in a group of 35 low birthweight infants (< 34 wk of gestation). 27 babies (77%) had clinical signs of infection confirmed by positive blood cultures and were compared to 8 (23%) uninfected matched patients. Seventeen (63%) of them had bacterial infection and 10 (37%) had fungal infection (Candida). Serum PCT (Brahms Diagnostika) and CRP (Immunoassay Vitros 950) were measured serially at 3, 7 and 10d of life.
RESULTS: At any time, PCT and CRP levels were significantly higher in neonates with perinatal infection (p < 0.05) (> 0.7 ng ml(-1) and > 1 mg dl(-1) respectively). PCT showed a more rapid response to infection (9.3 +/- 1.5 ng ml(-1)). especially to bacterial infection (10.8 +/- 1.4 ng ml(-1)), than CRP (1.5 +/- 0.5 mg dl(-1)) (sensitivity 99% vs 88%). Lower sensitivity was noted for both parameters. PCT and CRP, to follow babies with fungal infection (6.7 +/- 0.8 ng ml(-1) and 0.9 +/- 0.7 mg dl(-1), respectively) (sensitivity 77% vs 58%).
CONCLUSION: This study gives PCT reference values in preterm babies with perinatal infection. In these babies, PCT seems to be more sensitive than CRP as a diagnostic marker of infection. Both parameters can be used alone or in combination for a better identification and follow-up of bacterial and fungal infection during the perinatal period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046277

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  5 in total

1.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Hervé Aube; Nils-Olivier Olsson; Bernard Blettery
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

2.  The role of procalcitonin in neonatal intensive care unit patients with candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Antonella Rella; Giovanna Barbuti; Fabio Manca; Osvaldo Montagna; Nicola Laforgia; Giuseppina Caggiano
Journal:  Folia Microbiol (Praha)       Date:  2012-06-12       Impact factor: 2.099

3.  Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin.

Authors:  José B López Sastre; David Pérez Solís; Vicente Roqués Serradilla; Belén Fernández Colomer; Gil D Coto Cotallo; Xavier Krauel Vidal; Eduardo Narbona López; Manuel García del Río; Manuel Sánchez Luna; Antonio Belaustegui Cueto; Manuel Moro Serrano; Alfonso Urbón Artero; Emilio Alvaro Iglesias; Angel Cotero Lavín; Eduardo Martínez Vilalta; Bartolomé Jiménez Cobos
Journal:  BMC Pediatr       Date:  2006-05-18       Impact factor: 2.125

4.  Early-Onset Neonatal Sepsis: Still Room for Improvement in Procalcitonin Diagnostic Accuracy Studies.

Authors:  Claudio Chiesa; Lucia Pacifico; John F Osborn; Enea Bonci; Nora Hofer; Bernhard Resch
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Age-specific percentile-based reference curve of serum procalcitonin concentrations in Japanese preterm infants.

Authors:  Noriko Fukuzumi; Kayo Osawa; Itsuko Sato; Sota Iwatani; Ruri Ishino; Nobuhide Hayashi; Kazumoto Iijima; Jun Saegusa; Ichiro Morioka
Journal:  Sci Rep       Date:  2016-04-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.